Esther Need

This study demonstrates that FOLR1-targeted Actinium-225 alpha-particle therapy effectively treats ovarian cancer with high tumor regression and survival rates while minimizing toxicity.

The paper develops radiotracers for CD47/SIRPα axis imaging and evaluates their biodistribution in mice, showing potential for optimizing therapeutic strategies.

This study shows that targeting mitochondrial metabolism with Atovaquone enhances radiotherapy effectiveness in pediatric rhabdoid tumors by improving tumor oxygenation.